About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT01141907

Nurse-Led Heart Failure Care Transition Intervention for African Americans: The Navigator Program

Heart failure (HF) affects over 5 million Americans with HF morbidity reaching epidemic proportions. Annual rates of new and recurrent HF events including hospitalization and mortality are higher amon...

Lead sponsor: Johns Hopkins University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Johns Hopkins University

Collaborators

National Institute of Nursing Research (NINR)

Age

21 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•hospitalized with admitting diagnosis of heart failure in prior 8 weeks
•self-identified as African American
•community-dwelling (i.e., not in a long-term care facility)
•residence within a predefined radius in Baltimore City
•working telephone in their home
•provide signed informed consent

Exclusion Criteria

•cannot speak or understand English
•severe renal insufficiency requiring dialysis
•acute myocardial infarction within preceding 30 days
•receiving home care services for HF post discharge
•legally blind or have major hearing loss
•screen positive for cognitive impairment on the Mini-cog at baseline
•unable to stand independently on a weight scale (limited ability to participate in HAT system)
•weigh more than 325 pounds (exceed scale capacity)
•serious or terminal condition such as psychosis or cancer (actively receiving chemo or radiation)
•pregnant

Related studies

MRI Assessment of Pulmonary Edema in Acute Heart Failure

NCT03999138 · Acute Heart Failure, Pulmonary Edema With Heart Failure

RECRUITINGPhase 2

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

NCT06762964 · Fontan Circulation, Single Ventricle Heart Disease, and more

Biomarker Guided Discharge of Heart Failure Patients

NCT03103932 · Heart Failure; With Decompensation

Assessing Systemic Circulation and LV Performance in Adults

NCT04347655 · Heart Failure

RECRUITINGPhase 2

A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

NCT07083011 · Heart Failure With Preserved Ejection Fraction

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 19, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment11

Start dateFeb 2010

Last updatedFeb 19, 2019

Condition

Locations shown

Johns Hopkins Hospital

Baltimore, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 19, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions